Entrada Therapeutics (TRDA) Asset Utilization Ratio (2023 - 2026)
Entrada Therapeutics' Asset Utilization Ratio came in at 0.01 for Q2 2026, down 91.3% from 0.17 a year earlier and down 8.2% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Asset Utilization Ratio (2023 - 2026) Analysis & Trends
For FY2025, Entrada Therapeutics' Asset Utilization Ratio was 0.06, down 86.7% from FY2024.
- Going back by year, Asset Utilization Ratio was 0.42 in FY2024 (+18.4%) and 0.36 in FY2023.
- The Q2 2026 figure represents the lowest quarterly Asset Utilization Ratio in data going back to Q1 2023.
- Year-over-year, Asset Utilization Ratio has declined for five consecutive quarters, with an average decline of 29.3% over the last eight quarters.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q2 2024 (growth of 389.1%), and the weakest in Q1 2026 (a decline of 95.3%).
- Business Quant data shows TRDA's Asset Utilization Ratio at 0.02 (Q1 2026), 0.06 (Q4 2025) and 0.14 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | Entrada Therapeutics | 195.28 Mn | -164.13 Mn | - | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | 0.14 |
| Jun 30, 2025 | 0.17 |
| Mar 31, 2025 | 0.34 |
| Dec 31, 2024 | 0.39 |
| Sep 30, 2024 | 0.38 |
| Jun 30, 2024 | 0.44 |
| Mar 31, 2024 | 0.33 |
| Dec 31, 2023 | 0.27 |
| Sep 30, 2023 | 0.18 |
| Jun 30, 2023 | 0.09 |
| Mar 31, 2023 | 0.07 |
API Access
Entrada Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();